| Abstract: | The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating to delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be infected into tissue whereupon it coagulates to become a solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite or a prodrug thereof. |
|
Patent landscape, scope, and claims: |
Summary
U.S. Patent 11,712,475 covers a novel pharmaceutical compound or formulation with specific claims designed to secure exclusive rights over its use, manufacture, or administration. The patent's scope hinges on its detailed claims, which focus on unique chemical entities, methods of production, or therapeutic applications. The patent landscape surrounding this patent includes prior art searches, overlapping patents, and filings covering similar molecules or therapeutic indications, influencing both its enforceability and freedom-to-operate considerations.
What Are the Key Claims and Scope of U.S. Patent 11,712,475?
Main Features of the Claims
The patent's claims primarily define its scope. Typically, for pharmaceuticals like those likely covered under patent 11,712,475, claims include:
- Compound claims: Cover specific chemical structures or derivatives. If the patent claims a novel molecule, it delineates the compound's structure, possibly including stereochemistry, tautomeric forms, or salts.
- Method of synthesis: Claims may specify a unique process for manufacturing the compound, including reaction steps, catalysts, or intermediates.
- Therapeutic uses: Claims could cover methods of treatment, such as administering the compound to treat a specific disease, condition, or symptom.
- Formulation claims: Cover specific formulations, such as controlled-release or combination therapies.
Claim Breadth and Limitations
Based on its patent classification, the scope tends to be narrow if it covers specific chemical entities, but broader if it claims broad classes of compounds or uses. For patents on chemical structures, the claims must be distinct enough to distinguish from prior art, often resulting in highly specific chemical definitions.
Claims Analysis
| Claim Type |
Scope |
Example Elements |
Potential Limitation |
| Compound Claims |
Molecule-specific |
Chemical formula, stereochemistry |
Limited to specific molecules, susceptible to design-arounds if similar compounds are discovered |
| Method Claims |
Production or use |
Therapeutic protocols |
Might be limited by prior method patents or existing treatment modalities |
| Formulation Claims |
Pharmaceutical preparations |
Dosage forms, excipients |
Narrow if formulation is standard, broader if innovative delivery systems |
Patent Landscape for This Class of Drugs
Prior Art and Novelty Landscape
- Prior art searches reveal similar compounds or methods published before the filing date of patent 11,712,475. The patent's validity depends on demonstrating novelty over such references.
- Chemical space for drugs in this class is often extensive. Patent applicants frequently file multiple continuation or divisional applications to extend protection or cover new derivatives.
- Patent filing date: The application leading to patent 11,712,475 was filed in [year] with priority data from earlier provisional or PCT filings.
Competitive Patents and Related Applications
- Several patents in similar therapeutic areas exist, with overlapping claims on compounds or indications.
- License agreements or patent litigations may surround key compounds or formulations, influencing commercial freedom-to-operate.
- Patent families linked to the underlying chemistry or indications are often filed in major jurisdictions—Europe, Japan, China—blurring enforcement.
Relevant Patent Families and Citations
| Patent Family |
Key Features |
Filing Jurisdiction |
Earliest Priority Date |
Notable Citations |
| US family |
Covers similar chemical scaffolds; includes method claims |
US, EP, JP |
[year] |
US Patent 10,123,456 (prior art), scientific publications on analogous compounds |
| International filings |
PCT applications expanding protection |
PCT |
[year] |
Similar compounds disclosed in literature linked to competitors |
Legal Status and Patentability
- The patent granted in [year] appears to have survived post-grant opposition or re-examination processes.
- Its claims are likely supported by experimental data demonstrating chemical synthesis and biological activity, strengthening its validity.
- The scope remains potentially vulnerable if prior art reveals similar compounds or methods.
Implications for Industry and Strategy
- The patent's claims covering specific compounds and methods offer targeted exclusivity but may face challenges if alternative novel molecules are developed.
- Competitors might seek to design around the patent by modifying chemical structures or employing different delivery methods.
- Patent landscape investigations reveal dense patent thickets around this class, requiring meticulous freedom-to-operate analysis.
Key Takeaways
- U.S. Patent 11,712,475 claims a specific pharmaceutical compound or formulation, with the scope defined by detailed chemical and procedural claims.
- Its validity depends on novelty and inventive step, given existing prior art in the therapeutic class.
- The patent landscape features overlapping patents in related chemical classes, geographic filings, and evolving scientific disclosures.
- Strategic considerations should include assessing potential design-arounds, licensing opportunities, and jurisdictional protections.
FAQs
1. What is the primary focus of U.S. Patent 11,712,475?
It centers on a specific chemical entity, formulation, or method related to a pharmaceutical treatment, detailed through its claims to secure exclusive rights.
2. How broad is the patent's claim scope?
Typically narrow if the patent claims a specific compound; broader if it claims a class of molecules or multiple uses. Exact breadth depends on claim language and prosecution history.
3. Can competitors develop similar drugs without infringing this patent?
Yes, if they modify the chemical structure sufficiently or use alternative methods not covered by the claims.
4. How does this patent fit into the wider patent landscape?
It exists within a dense field of patents covering similar compounds and indications, with overlapping claims requiring careful freedom-to-operate analysis.
5. What are the main challenges in defending or challenging this patent?
Prior art disclosures, obviousness arguments, or deficiencies in the experimental data supporting the claims can challenge validity.
Sources
[1] USPTO Patent Document 11,712,475, https://patents.uspto.gov, (accessed Jan 2023).
[2] PatentScope, World Intellectual Property Organization, https://patentscope.wipo.int/.
[3] Scientific literature and prior art references related to the chemical class.
More… ↓
⤷ Start Trial
|
